insights_auto
Zašto je MYGN skočio 2,62%?
Istražite detaljnijechevron_right
MYGN:NASDAQ
Myriad Genetics Inc
4,31 USD
arrow_upward
+2,62%(+0,11) 1D
4,31 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 9. lis, 16:00:01 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za MYGN...
Otvori
4,18 USD
Najviša
4,40 USD
Najniža
4,15 USD
Trž. kap.
412,25 mil.
Prosj. kol.
2,03 mil.
Količina
1,37 mil.
52-tjed. najviša
8,59 USD
52-tjed. najniža
2,74 USD
EPS
−1,20 USD
Beta
1,64
Dionice u optjecaju
95,65 mil.
Broj djelatnika
3 tis.
Otvori
4,18 USD
Najviša
4,40 USD
Najniža
4,15 USD
Trž. kap.
412,25 mil.
Prosj. kol.
2,03 mil.
Količina
1,37 mil.
52-tjed. najviša
8,59 USD
52-tjed. najniža
2,74 USD
EPS
−1,20 USD
Beta
1,64
Dionice u optjecaju
95,65 mil.
Broj djelatnika
3 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
TipRanks
·
prije 20 sati
Myriad Genetics Finalizes Separation Agreement With Former CCO
Stock Titan
·
prije 2 dana
A prostate cancer score may help group patients in treatment trials
Profil
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Myriad Genetics Inc – informacije
Glavni izvršni direktorPaul J. Diaz | Paul J. Diaz
Zaposlenici2,7 tis.
Osnovano1991
SjedišteSalt Lake City, Utah, Sjedinjene Američke Države
Sektor-
Web-lokacijamyriad.com